Speech Core, Pennsylvania State University
University Park, Pennsylvania, 16802, United States
Location status: Recruiting
NCT Number: NCT06819124
The goal of this clinical trial is to learn about the effect of communicative interaction on verbal communication in people with amyotrophic lateral sclerosis (ALS) and their caregivers.
The question is, What are the effects of communicative interaction on verbal communication in people with ALS when they interact with their caregivers and does this change over time?
Participants will read words and sentences while they are interacting with their caregivers.
Interested in participating?
Request Info18 year–90 year
All sexes
Interventional
Not applicable
University Park, Pennsylvania, 16802, United States
Location status: Recruiting
PALS and Caregivers will participate in two sets (pre-test and post-test) of interactive tasks two weeks apart. Over two weeks, they will complete the collaborative word-matching task ten times (once every weekday for an average of 10 mins/day) on their own.
The study is designed to examine two things. First, to examine the speech produced by PALS with familiar interlocutors. Second, to examine the changes in speech production as a function of collaborative practice.
Plans for Assignment - This is a single group study in which all participants will engage in the same tasks.
Delivery of Intervention: Using tablets and audio recording devices provided to them, participants will complete this task in the comfort of their home. Study protocols will be explained via videoconferencing by experimenters. Produced speech will be recorded using solid-state audio recorders as well as remotely through the video conferencing software.
Adequacy of Sample size. Assuming medium effect sizes (Cohen's f = 0.3) based on our pilot data, for 80% power at an alpha of .05, the investigators will require 76 speakers. The investigators propose n =76 PALS and their caregivers (total 152) in order to account for speech variability that is common for PALS.
Adequacy of Analyses. The proposed statistical analyses (Generalized mixed effects regressions) are standard and will be used to analyze the effect of the intervention on the outcome measures described below. Severity of condition (for PALS) will be included in the analyses and by-subject slopes and intercepts will be used to account for variability across participants.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Speakers with amyotrophic lateral sclerosis (ALS) (PALS-people with ALS)
Caregivers
Exclusion criteria
Two interlocutors, one with ALS and their caregiver will work together. Each participant in the pair will view the same set of words on their screens. After one second, one of the words will be highlighted on the speaker's screen, they will say the word in the phrase "Click on the ____ this time", and the listener will click on it. After the listener has made their selection, both participants will receive feedback on trial success.
Two interlocutors, one with ALS and their caregiver will work together. The pairs will be presented with two different versions of the same picture with eight differences chosen to elicit the same target segments (e.g., "hid", "ship", "net"). These pictures will be modified from the LUCID corpus. In total, pairs will complete four picture sets per session. Pairs will be given 5 minutes for each picture set.
Time frame: two 60 minute sessions
Formant frequencies that characterize speech sounds will be made on speech recorded in the intervention task.
Time frame: two 60 minute sessions
Perceptual judgments will be provided by solo, naïve listeners who did not participate in the interactions. Listeners will hear recorded speech of PALS and age-matched speakers recorded across the different tasks and indicate what they heard. The score will be expressed in percent. The possible range is between 0-100%. The higher scores mean a better outcome.
Time frame: Two 60 minute sessions
Syntactic complexity in the unstructured communication task will be measured through mean length of grammatical units, clausal density, and clause type. Each variable will be assessed at both the dyadic level (e.g., clausal density for both interlocutors together) and at the level of the individual speaker (e.g., clausal density of each speaker). A composite of these measures will provide an index of the syntactic complexity of the conversation.
Time frame: Two 60 minute sessions
The investigators will count the number and duration of silent portions of speech, filled pauses, linguistic mazes, speaking turns, and interruptions in the unstructured communication task. A composite measure of the individual measures will provide an index of an individual's contribution to the conversation.
Time frame: two 60 minute sessions
Durations that characterize speech sounds will be made on speech recorded in the intervention task.
Contact information is provided by the study sponsor or research team.
Anne Olmstead, Ph.D.
CONTACT
Navin Viswanathan, Ph.D
CONTACT
Penn State University
Other
Examining Interactions Between Persons With ALS and Caregivers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07257302
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS)
Kodaira, Tokyo, Japan
View Trial DetailsNCT07023835
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS)
La Jolla, California, United States
View Trial DetailsNCT07726563
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS)
Taipei City, Taipei, Taiwan
View Trial DetailsNCT07142291
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS)
Scottsdale, Arizona, United States
View Trial Details